Table 2.
Vaccination history | Month 0 | Month 1 | Month 2 | After month 2 |
---|---|---|---|---|
Unvaccinated |
Hib/MenACWY First dose PCV Seasonal influenzaa |
MenB | MenACWY |
PPV at least 2 months after PCV Seasonal influenzaa |
PPV |
Hib/MenACWY/MenB PCV (at least 1 year after PPV) Seasonal influenzaa |
MenB | MenACWY |
MenACWY every 5 years PPV 5 years after PPV Seasonal influenzaa |
MenACWY/MenB vaccination (> 5 years) |
Hib/MenACWY PCV13 (at least 1 year after PPV) Seasonal influenzaa |
MenB | MenACWY |
MenACWY every 5 years PPV 5 years after PPV Seasonal influenzaa |
Completed MenACWY/MenC; Hib and PCV vaccination more than 5 years before |
Hib/MenACWY PCV Seasonal influenzaa |
MenB | PPV |
MenACWY every 5 years PPV 5 years after PPV Seasonal influenza∞ |
Timing: Functional asplenia—as soon as possible. Surgical asplenia (elective)—complete the vaccination schedule 4–6 weeks before surgery; if not possible, complete at least 2 weeks before surgery. Surgical asplenia (emergency)—start the vaccination schedule at least 2 weeks after the operation or as soon as the clinical conditions permit
PCV pneumococcal conjugate vaccine, PPV pneumococcal polysaccharide vaccine, Hib H. influenzae type b vaccine, MenACWY N. menigitidis serotypes A, C, W, Y vaccine, MenC N. meningitidis C vaccine
aOtherwise healthy asplenic patients 2–49 years of age may be vaccinated with live attenuated influenza vaccine, except patients with sickle cell disease, who should receive inactivated influenza vaccine